"台灣神隆"克拉屈濱
Country: Taiwan
Language: Chinese
Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
Public Assessment Report
(PAR)
02-03-2022
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
台灣神隆股份有限公司 台南市善化區南科八路１號 (16130161)
ATC code:
L04AA40
Pharmaceutical form:
（粉）
Units in package:
HDPE圓桶裝
Class:
原料藥
Prescription type:
製劑原料
Manufactured by:
台灣神隆股份有限公司 台南市善化區南科八路１號 TW
Therapeutic area:
cladribine
Therapeutic indications:
復發型多發性硬化症(臨床上有發作，且前兩年有兩次復發者)。
Product summary:
有效日期: 2026/10/21; 英文品名: Cladribine "SP"
Authorization date:
2021-10-21
